Top View
- A (Naphazoline Hydrochloride/ Antazoline Phosphate) Eye Drops
- Antazoline in the Treatment of Cardiac Arrhythmias S. S. SHAH C. H
- Antazoline Hydrochloride
- Collection and Processing of Drug Information: National Ambulatory Medical Care Survey United States, 1980
- List Item Opatanol : EPAR
- (Therapeutic Products) Regulations 2015
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Antihistamines
- PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2016) Annotated for Statistical Reporting Purposes
- (12) United States Patent (10) Patent No.: US 8,829,005 B2 Abelson Et Al
- Caloptima Approved Drug List
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- (12) Patent Application Publication (10) Pub. No.: US 2017/0020873 A1 Mitchell (43) Pub
- Prevalence of Psychoactive Substances in the General Population
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Documentation for All Data Sets
- Customs Tariff - Schedule Xxi - 1
- Therapeutic Class Overview Ophthalmic Antihistamines
- Antihistamine Drugs Possess Some Antiacetylcholine Properties
- Wo 2007/044693 A2
- Toxicology Brief” Was Contributed by Lisa Murphy, VMD, ASPCA Animal Poison Control Center, 1717 S
- Acrivastine/Astemizole 567
- Characterization of in Vitro and in Vivo Metabolism of Antazoline Using Liquid Chromatography-Tandem Mass Spectrometry
- Acrivastine/Astemizole 567
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Histamine H1-Receptor Antagonists: Antihistaminic Agents
- Ophthalmic Gel
- Prohibited Substances List This Is Not an Official Or Current List of FEI Prohibited Substances
- Switch List Updated June 21, 2021.Doc
- Antihistamines in Topical Preparations
- (12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al
- (12) Patent Application Publication (10) Pub. No.: US 2014/0094438 A1 Mitchell (43) Pub
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Non-Interventional Study Protocol
- 2017 Equine Prohibited Substances List
- Pharmaceutical Appendix to the Tariff Schedule 2
- Histamine and Antihistaminic Agents
- 2010 Nhamcs Micro-Data File Documentation Page 1
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Drug Formulary
- Sedating Antihistamines for 34Th
- 3 Develop/Anbessa/134-145 ÊÕ
- Drugs Cdl P2 1 Drugs: Contract Drugs List Part 2 – Over-The-Counter Drugs Page Updated: July 2021
- United States Patent Office
- What Are Dry Eyes?
- (12) Patent Application Publication (10) Pub. No.: US 2008/0085922 A1 Raja Et Al
- Treatment with Olopatadine and Naphazoline Hydrochloride Reduces Allergic Conjunctivitis in Mice Through Alterations in Inflammation, NGF and VEGF
- Schedule Lxxxix - Macao, China
- Some Cardiovascular Actions of Cyclizine, Chlorcyclizine and Homchlorcyclizine Have Been Re of These Extracardiac Actions